.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Michael Levy
Michael LevyOCTAGON CAPITAL

Michael Levy

CEO at OCTAGON CAPITAL

Investor

Deal Bio

Total Deals10
Valued Deals10
Total Value£1,672M
Avg. Deal Size£167M

Expertise (10)

Key Relationships

China
Pharmaceuticals
Cross BorderPrivate EquityMinorityAcquisitionPublic
I-MAB

target

I-MAB

Hillhouse Capital Group

bidder

Hillhouse Capital Group

£315m

33 dealmakers

United States
Pharmaceuticals
MinorityDomesticPrivate EquityAcquisitionPrivate
4d Molecular Therapeutics

target

4d Molecular Therapeutics

Mirae Asset Financial Group

bidder

Mirae Asset Financial Group

£56m

11 dealmakers

China
Medical Services
Cross BorderAcquisitionVenture CapitalMinorityPrivatePrivate Equity
Arctic Vision

target

Arctic Vision

Loyal Valley Capital

bidder

Loyal Valley Capital

£72m

6 dealmakers

China
Biotechnology
PrivateCross BorderAcquisitionVenture CapitalPrivate EquityMinority
Epimab Biotherapeutics

target

Epimab Biotherapeutics

Octagon Investments

bidder

Octagon Investments

£86m

16 dealmakers

United States
Biotechnology
PrivateVenture CapitalPrivate EquityMinorityAcquisitionCross Border
Century Therapeutics

target

Century Therapeutics

Fidelity Management & Research Company

bidder

Fidelity Management & Research Company

£115m

24 dealmakers

Singapore
Biotechnology
MinorityCross BorderAcquisitionPrivate EquityVenture CapitalPrivate
Hummingbird Bioscience

target

Hummingbird Bioscience

Frazier Healthcare Partners

bidder

Frazier Healthcare Partners

£88m

18 dealmakers

Switzerland
Biotechnology
AcquisitionCross BorderMinorityPrivatePrivate EquityVenture Capital
Numab Therapeutics

target

Numab Therapeutics

Novo Holdings

bidder

Novo Holdings

£78m

11 dealmakers

United States
Biotechnology
Cross BorderMinorityPrivateVenture CapitalAcquisitionPrivate Equity
Sonoma Biotherapeutics

target

Sonoma Biotherapeutics

Casdin Capital

bidder

Casdin Capital

£190m

15 dealmakers

China
Medical Equipment
Venture CapitalPrivateCross BorderPrivate EquityAcquisitionMinority
Edge Medical Robotics

target

Edge Medical Robotics

Octagon Capital

bidder

Octagon Capital

£148m

11 dealmakers

China
Biotechnology
AcquisitionPrivatePrivate EquityCross BorderVenture CapitalMinority
Abogen Biosciences

target

Abogen Biosciences

Invesco Asset Management

bidder

Invesco Asset Management

£520m

28 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US